English | Español
Patient Daily | Jan 13, 2026

AbbVie, Amgen and Lilly urge FDA reforms on drug manufacturing change rules
Patient Daily | Jan 13, 2026

UCSF Neurosurgery professor: 'Lots of evidence that 340B increases the cost of medications'
Patient Daily | Jan 13, 2026

Researchers discover new genetic links between fruit fly pigmentation and brain dopamine regulation
Patient Daily | Jan 13, 2026

J.P. Morgan Healthcare Conference marked by optimism but lacks major M&A announcements
Patient Daily | Jan 13, 2026

Patient advocacy groups urge Senate action on ACA enhanced tax credits
Patient Daily | Jan 12, 2026

Biopharma sector enters 2026 optimistic amid advances in rare disease policy
Patient Daily | Jan 12, 2026

Bristol Myers Squibb highlights early-stage research amid industry focus on late-stage deals
Patient Daily | Jan 12, 2026

Autologous T cell therapy shows early promise against pancreatic cancer in Baylor-led trial

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'